Due to their dopaminergic character, SH-SY5Y cells are generally considered as a model for Parkinson’s disease, however, they can be differentiated to dominantly cholinergic phenotype suitable for AD studies by treatment with retinoic acid (RA) and brain-derived neurotrophic factor (BDNF) [13]. Here, BDNF is linked to Parkinson disease.